Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation
Molecules · 17.03.2023 · 28 (6) · 2709
DOI: 10.3390/molecules28062709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 17.03.2023. Verfasst von Mingyang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Breast Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Fibroblast growth factor receptors (FGFRs) play critical roles in the regulation of cell growth, differentiation, and proliferation. Specifically, FGFR2 gene amplification has been implicated in gastric and breast cancer. Pan-FGFR inhibitors often cause large toxic side effects, and the highly conserved ATP-binding pocket in the FGFR1/2/3 isoforms poses an immense challenge in designing selective FGFR2 inhibitors. Recently, an indazole-based inhibitor has been discovered that can selectively target FGFR2. However, the detailed mechanism involved in selective inhibition remains to be clarified. To this end, we performed extensive molecular dynamics simulations of the apo and inhibitor-bound systems along with multiple analyses, including Markov state models, principal component analysis, a cross-correlation matrix, binding free energy calculation, and community network analysis. Our results indicated that inhibitor binding induced the phosphate-binding loop (P-loop) of FGFR2 to switch from the open to the closed conformation. This effect enhanced extensive hydrophobic FGFR2-inhibitor contacts, contributing to inhibitor selectivity. Moreover, the key conformational intermediate states, dynamics, and driving forces of this transformation were uncovered. Overall, these findings not only provided a structural basis for understanding the closed P-loop conformation for therapeutic potential but also shed light on the design of selective inhibitors for treating specific types of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Orthopedic Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
- Institute of Energy Metabolism and Health, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
- Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
- Department of Liver Surgery and Transplantation, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Hepatic Surgery, Shanghai Geriatric Cancer, Shanghai 201104, China.
ORCID-Profile: Mingyang Zhang, De-Ning Ma
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M., Yasen, M., Lu, S., Ma, D. N., & Chai, Z. (2023). Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation. Molecules, 28(6), 2709. https://doi.org/10.3390/molecules28062709
Vancouver
Zhang M, Yasen M, Lu S, Ma DN, Chai Z. Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation. Molecules. 2023;28(6):2709. doi:10.3390/molecules28062709
BibTeX
@article{Zhang2023,
author = {Zhang, Mingyang and Yasen, Miersalijiang and Lu, Shaoyong and Ma, De-Ning and Chai, Zongtao},
title = {Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation},
journal = {Molecules},
year = {2023},
volume = {28},
number = {6},
pages = {2709},
doi = {10.3390/molecules28062709}
}
EUVIMED